33
Participants
Start Date
May 31, 2002
Primary Completion Date
June 30, 2005
Study Completion Date
January 31, 2009
Allogeneic Stem Cell Transplantation
An infusion of HLA matched unrelated bone marrow or peripheral blood stem cells.
Chemotherapy and antibodies
Participants received a standard conditioning regimen consisting of total body irradiation, cyclophosphamide, thiotepa and ATG. GVHD prophylaxis consisted of cyclosporine and Methotrexate.
St. Jude Children's Research Hospital, Memphis
St. Jude Children's Research Hospital
OTHER